Fiona Cookson
Head of US Media Relations
@astrazeneca.com+12128XXXXXX
Mark T. Esser
Vice President and Head of Microbial Sciences, BioPharmaceuticals R&D
@astrazeneca.com
Ruth March
Senior Vice-President of Precision Medicine, R&D Oncology
@astrazeneca.com
Adam Platt
VP and Head of Translational Science and Experimental Medicine, Respiratory and Immunology
@astrazeneca.com
Nazneen Rahman
Non-Executive Director
@astrazeneca.com
Sofia Tapani
Head of Early Respiratory & Immunology Statistics, Executive Director Statistics
@astrazeneca.com
Ruud Dobber
Executive Vice-President, BioPharmaceuticals Business Unit
@astrazeneca.com
Suzanne Cohen
Executive Director and Head of Bioscience Asthma and Skin Immunity, Respiratory and Immunology (R&I)
@astrazeneca.com
Aradhana Sarin
Executive Director and Chief Financial Officer
@astrazeneca.com
Pam Cheng
Executive Vice President, Global Operations, IT & Chief Sustainability Officer
@astrazeneca.com
Marcus Wallenberg
Non-Executive Director
@astrazeneca.com
Mina Makar
Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit
@astrazeneca.com
Victoria Parker
Executive Group Director, Metabolism, Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D
@astrazeneca.com
Iskra Reic
Executive Vice-President, International
@astrazeneca.com
Rene Haas
Non-Executive Director
@astrazeneca.com
Philip Broadley
Senior independent Non-Executive Director
@astrazeneca.com
Diana Layfield
Non-Executive Director
@astrazeneca.com
Susan Galbraith
Executive Vice-President, Oncology R&D
@astrazeneca.com
David Fredrickson
Executive Vice-President, Oncology Business Unit
@astrazeneca.com
Sonny Shergill
Vice President, Commercial Digital Health
@astrazeneca.com
Tom Keith-Roach
President, AstraZeneca UK
@astrazeneca.com
Karen Knudsen
Non-Executive Director
@astrazeneca.com
Nayyar Iqbal
Vice President Clinical Metabolism, BioPharmaceuticals R&D
@astrazeneca.com
Clive Green
Executive Director and Head of Global Sample Management, Discovery Sciences, R&D
@astrazeneca.com
Ryan Hicks
Head of Bioscience Cell Therapy, BioPharmaceuticals R&D
@astrazeneca.com
Shawn Davis
Head of Drug Delivery, BioPharmaceuticals Development, R&D
@astrazeneca.com
Annette Bak
Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D
@astrazeneca.com
Birgit Conix
Non-Executive Director
@astrazeneca.com
Sheri McCoy
Non-Executive Director
@astrazeneca.com
Ken Grime
Executive Director and Head of Bioscience COPD & IPF, Respiratory & Immunology (R&I)
@astrazeneca.com
Mikhail Kosiborod
Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D
@astrazeneca.com
Malin Lemurell
Executive Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D
@astrazeneca.com
Senior Vice President, Biologics Engineering & Oncology Targeted Delivery
Senior Vice President, Biologics Engineering & Oncology Targeted Delivery
@astrazeneca.com
Tonya Villafana
Vice President, Global Franchise Head, Infection
@astrazeneca.com
Slavé Petrovski
VP, Centre for Genomics Research, BioPharmaceuticals R&D
@astrazeneca.com
Sharon Barr
Executive Vice-President, BioPharmaceuticals R&D
@astrazeneca.com
Jeff Pott
Chief Human Resources Officer, Chief Compliance Officer and General Counsel
@astrazeneca.com
Martin Cowie
Vice President Clinical Cardiovascular and Renal Clinical Development, BioPharmaceuticals R&D
@astrazeneca.com
Pascal Soriot
Executive Director and Chief Executive Officer
@astrazeneca.com
Steve Rees
SVP, Discovery Sciences, R&D
@astrazeneca.com
Marc Dunoyer
Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca
@astrazeneca.com
Andy Barnett
Head of Investor Relations
@astrazeneca.com
Cassie Gregson
Vice President, R&D IT
@astrazeneca.com
Lutz Jermutus
Head of Projects
@astrazeneca.com
Euan Ashley
Non-Executive Director
@astrazeneca.com
Regina Fritsche-Danielson
Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D
@astrazeneca.com
Shalini Andersson
Vice President Oligonucleotide Discovery, Discovery Sciences
@astrazeneca.com
Tony Mok
Non-Executive Director
@astrazeneca.com
Kenny Hansson
Executive Director and Head of Bioscience Cardiovascular, Cardiovascular, Renal and Metabolism (CVRM)
@astrazeneca.com
Anna Manz
Non-Executive Director
@astrazeneca.com
Cristina Durán
Chief Digital Health Officer, R&D
Michel Demaré
Non-Executive Chair of the Board
Rasmus Jansson-Löfmark
Executive Director and Head of DMPK, Early CVRM
Lauren-Jei McCarthy
Director, US Media Relations
@astrazeneca.com+13479XXXXXX
Freja Annamatz
Director, Media Relations, Sweden
@astrazeneca.com+46722XXXXXX
Ricardo Blanco
Director, Media Relations, Latin America
@astrazeneca.com
Isabel Gibson
Director of Investor Relations (Oncology)
@astrazeneca.com
Elizabeth Walton
Director of Investor Relations (BioPharmaceuticals (Respiratory & Immunology))
@astrazeneca.com
Tina Rydén-Bergsten
Global Product Leader, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D
@astrazeneca.com
Nicolas Jose Guzman
Director Physician, Nephrology Clinical Research
@astrazeneca.com
Andrew Christmas
Director of Investor Relations (Rare Disease and Sustainability)
@astrazeneca.com
Lishan Soon
Senior Director, International Communication
@astrazeneca.com
Christer Gruvris
Executive Director of Investor Relations (BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income)
@astrazeneca.com
Philip Sparks
Director of Investor Relations (BioPharmaceuticals (Vaccines & Immune Therapies) and Sustainability)
@astrazeneca.com
Ola Engkvist
Associate Director, Computational Chemistry, Discovery Sciences, R&D
@astrazeneca.com
Lauren Swales
Director of Investor Relations (Rare Disease)
@astrazeneca.com
Louise Pearson
Director of Investor Relations (Oncology)
@astrazeneca.com
Simon Bradford
Data & Analytics Enabling Units Engineering Lead
@astrazeneca.com
Tatiana Scetinina
Director, Data Science
@astrazeneca.com
Fredrik Röök
Transaction Director, Business Development Operations
918209999Active
AstraZeneca AB